Ron Bentsur
Co-Founder, Chairman, CEO & PresidentMr. Ron Bentsur, M.B.A. is a Co-Founder of Nuvectis Pharma, Inc. on July 27, 2020 and serves as its Chairman, Chief Executive Officer and President since 2020. He has been Advisor of UroGen Pharma Ltd. since January 3, 2019. Mr. Bentsur served as Independent Director of Stemline Therapeutics, Inc. since 2009 until June 10, 2020. He served as Director of Beyond Air, Inc. (formerly known as Advanced Inhalation Technologies, Ltd.) since August 2015 until March 14, 2025. Mr. Bentsur was Chief Executive Officer of UroGen Pharma Ltd. since August 2015 until January 3, 2019 and its Director since October 2015 until January 3, 2019. He has experience in the biotech industry. Mr. Bentsur served as the Chief Executive Officer of Keryx Biopharmaceuticals, Inc. since May 2009 until May 2015 and as a Member of its Board of Directors. He served as Chief Executive Officer of XTL Biopharmaceuticals Ltd., a position he held from January 2006 until April 2009. From October 2000 Mr. Bentsur was with Keryx and served as Vice President of Finance and its Chief Financial Officer from June 2003 until his departure in January 2006. He serves as a Director at Nuvectis Pharma, Inc. From July 1998 to October 2000, Mr. Bentsur served as Director of Technology Investment Banking at Leumi Underwriters. From June 1994 to July 1998, he worked as an investment banker in New York City, spending most of this period at ING Barings Furman Selz. Mr. Bentsur holds a B.A. in Economics and Business Administration with distinction from the Hebrew University of Jerusalem, Israel and an M.B.A. (Magna Cum Laude), from New York University Stern Graduate School of Business.
Positions
- Company NameNuvectis Pharma, Inc.Stock CodeNVCTPositionCo-Founder, Chairman, CEO & PresidentColleagues
- EPEnrique PoradosuCo-Founder, Executive VP, Chief Scientific & Business Officer
- SSShay ShemeshCo-Founder, Executive VP, Chief Development & Operations Officer
- MCMichael CarsonVice President of Finance
- KHKenneth HobermanIndependent Director
- JFJames F. OlivieroIndependent Director
- MLMatthew Lee KaplanIndependent Director
- SNShannon N. WestinMember of Scientific Advisory Board
